Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinically Significant Portal Hypertension (CSPH) on Early-stage HCC Following Hepatectomy: What's the Impact?

NCT05402644 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT05402644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinically Significant Portal Hypertension (CSPH) on Early-stage HCC Following Hepatectomy: What's the Impact?
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2009
Completion date
January 1, 2022
Enrollment
320 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, portal hypertension